Toth Financial Advisory Corp lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 11.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,470 shares of the company’s stock after selling 3,713 shares during the period. Toth Financial Advisory Corp’s holdings in Express Scripts Holding were worth $1,818,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ESRX. Park National Corp OH boosted its position in shares of Express Scripts Holding by 0.3% in the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares during the last quarter. Hayek Kallen Investment Management boosted its position in shares of Express Scripts Holding by 0.5% in the first quarter. Hayek Kallen Investment Management now owns 7,778 shares of the company’s stock worth $513,000 after buying an additional 40 shares during the last quarter. Barry Investment Advisors LLC boosted its position in shares of Express Scripts Holding by 0.6% in the first quarter. Barry Investment Advisors LLC now owns 7,986 shares of the company’s stock worth $526,000 after buying an additional 50 shares during the last quarter. Transamerica Financial Advisors Inc. boosted its position in shares of Express Scripts Holding by 0.3% in the first quarter. Transamerica Financial Advisors Inc. now owns 30,032 shares of the company’s stock worth $1,980,000 after buying an additional 77 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. boosted its position in shares of Express Scripts Holding by 0.5% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 16,445 shares of the company’s stock worth $1,013,000 after buying an additional 81 shares during the last quarter. 90.24% of the stock is owned by institutional investors and hedge funds.

Shares of Express Scripts Holding Company (NASDAQ ESRX) traded up 0.83% on Wednesday, reaching $62.24. The company had a trading volume of 792,868 shares. Express Scripts Holding Company has a 1-year low of $57.80 and a 1-year high of $77.61. The firm has a market capitalization of $35.95 billion, a price-to-earnings ratio of 10.80 and a beta of 0.90. The firm has a 50-day moving average price of $62.51 and a 200 day moving average price of $64.30.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. Express Scripts Holding’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.57 EPS. Equities research analysts predict that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding Company (ESRX) Shares Sold by Toth Financial Advisory Corp” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/express-scripts-holding-company-esrx-shares-sold-by-toth-financial-advisory-corp/1495917.html.

A number of brokerages have commented on ESRX. UBS AG set a $71.00 target price on Express Scripts Holding and gave the company a “hold” rating in a report on Tuesday, April 25th. Jefferies Group LLC set a $88.00 target price on Express Scripts Holding and gave the company a “buy” rating in a report on Thursday, April 20th. Morgan Stanley reduced their target price on Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating for the company in a report on Wednesday, April 26th. BidaskClub raised Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Finally, SunTrust Banks, Inc. reissued a “buy” rating on shares of Express Scripts Holding in a report on Tuesday, April 25th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Express Scripts Holding presently has a consensus rating of “Hold” and a consensus price target of $71.17.

In other Express Scripts Holding news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares in the company, valued at approximately $667,368.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.